Stem Cells in Drug Discovery & Toxicity Screening 2018

Date: Thursday, 4 October 2018 - Friday, 5 October 2018
Location: Coronado Island, California

Keynote Speakers

Norio Nakatsuji
Chief Advisor, Stem Cell & Device Laboratory, Inc. (SCAD); Professor Emeritus, Kyoto University

Mark Bradley
Professor of Therapeutic Innovation, Precision Healthcare University Research Institute, Queen Mary University of London

Reyk Horland
CEO, TissUse GmbH

Gary Gintant
Senior Research Fellow, Abbvie

Nancy Allbritton
Kenan Professor of Chemistry and Biomedical Engineering and Chair of the Joint Department of Biomedical Engineering, University of North Carolina and North Carolina State University

Paul Gatenholm
Professor, Director of 3D Bioprinting Center, Chalmers University of Technology, Sweden; CEO, CELLHEAL AS, Norway

Roger Kamm
Cecil and Ida Green Distinguished Professor of Biological and Mechanical Engineering, Massachusetts Institute of Technology (MIT)

Linda Griffith
Professor, Massachusetts Institute of Technology (MIT)

Shoji Takeuchi
Professor, Center For International Research on Integrative Biomedical Systems (CIBiS), Institute of Industrial Science, The University of Tokyo

James Hickman
Professor, Nanoscience Technology, Chemistry, Biomolecular Science and Electrical Engineering, University of Central Florida; Chief Scientist, Hesperos

Overview

SELECTBIO Stem Cells in Drug Discovery, and Toxicity Screening 2018 brings together researchers from around the world focusing on the emerging technologies and applications in cellular analysis.

The following conferences are co-Located and concurrent and Delegates can Participate, Mix-and-match presentations and network extensively.

Co-Located, Concurrent Conference Tracks:
Organ-on-a-Chip World Congress 2018
3D-Bioprinting 2018
Stem Cells in Drug Discovery and Toxicity Screening 2018
3D-Culture & Organoids 2018
Hear from and network with researchers who are currently screening for efficacy and toxicity using iPS cell lines, and those responsible for developing the techniques and technologies. There will also be discussions on industry and regulatory developments that are shaping the future of stem cell usage in drug discovery.

Key Opinion Leaders from around the World are Participating at this Conference allowing Maximal Information Exchange and Unparalleled Networking Opportunities.

Information and Local Registration Facilities for this Conference are also available in:

Japanese | Korean | Chinese (Simplified) | Chinese (Traditional)

Agenda Topics

3D-Cell Culture Based Models

Technologies in 3D-Cell Culture

iPSC-derived Cells for Toxicity Testing & Screening
Screening Technologies, Instrumentation and Reagents
Stem Cells in Drug Discovery and Development
Use of Microfluidics Organs-on-Chips for Toxicity Screening

Sponsorship and Exhibition Opportunities

Jeff Fan, Exhibition Manager
jeff@selectbioconferences.com
+1-510-857-4865

Confirmed Speakers to date

Ulrich Broeckel, Professor of Pediatrics, Medicine and Physiology - Chief, Section of Genomic Pediatrics, Medical College of Wisconsin
Guohao Dai, Associate Professor, Department of Bioengineering, Northeastern University
Toshihiko Ezashi, Research Associate Professor, The University of Missouri
Robert Halliwell, Professor of Neuroscience, University of The Pacific

Corporate Sponsors	Media Sponsors	Official Journal Partner	Networking

Add to Calendar ▼2018-10-04 00:00:002018-10-05 00:00:00Europe/LondonStem Cells in Drug Discovery and Toxicity Screening 2018Stem Cells in Drug Discovery and Toxicity Screening 2018 in Coronado Island, CaliforniaCoronado Island, CaliforniaSELECTBIOenquiries@selectbiosciences.com

Corporate Sponsors